Physician profile
Elise Brett
NPI 1407963424
$49,459.10
in general payments reported to CMS, 2019-2025
20 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $2,372 · 2021: $2,603 · 2022: $191 · 2023: $31K · 2024: $275 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $5,036 · Food and Beverage: $2,499 · Consulting Fee: $720 · Education: $62.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,498.19 |
| Travel and Lodging | $5,036.32 |
| Food and Beverage | $2,498.64 |
| Consulting Fee | $720.00 |
| Education | $62.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $41,508.54 | 2023-2025 | Yorvipath |
| Vistapharm, INC. | $2,437.82 | 2021 | |
| Horizon Therapeutics Plc | $2,116.50 | 2020 | |
| Alexion Pharmaceuticals, INC. | $830.50 | 2023 | Strensiq |
| Amgen INC. | $499.92 | 2019-2024 | Evenity |
| Fresenius Kabi USA, LLC | $356.96 | 2025 | Tyenne |
| Xeris Pharmaceuticals, INC. | $297.19 | 2023-2025 | Recorlev |
| Nevro Corp. | $165.48 | 2021 | |
| Insulet Corporation | $150.00 | 2024 | Omnipod |
| Beta Bionics, INC. | $138.94 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Merck Sharp & Dohme LLC | $125.00 | 2019 | |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Tandem Diabetes Care, INC. | $121.76 | 2019 | |
| Zealand Pharma US, INC. | $110.58 | 2020 | |
| Intuity Medical INC | $108.29 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $103.71 | 2019-2020 | |
| Abbott Laboratories | $95.71 | 2022 | |
| Amryt Pharma Holdings LTD | $94.95 | 2022 | |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $22.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Brett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.